Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPDGF-BB gel for chronic diabetic lower extremity skin ulcers
CTR20132176Phase 3Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of becaplermin in diabetic foot ulcer (DFU), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jan 2014; status: active.
02
Drugs
becaplermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20132176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132176.